Paul E. Wiedeman

843 total citations
20 papers, 437 citations indexed

About

Paul E. Wiedeman is a scholar working on Organic Chemistry, Molecular Biology and Immunology. According to data from OpenAlex, Paul E. Wiedeman has authored 20 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Paul E. Wiedeman's work include Veterinary medicine and infectious diseases (5 papers), Peptidase Inhibition and Analysis (4 papers) and Diabetes Treatment and Management (4 papers). Paul E. Wiedeman is often cited by papers focused on Veterinary medicine and infectious diseases (5 papers), Peptidase Inhibition and Analysis (4 papers) and Diabetes Treatment and Management (4 papers). Paul E. Wiedeman collaborates with scholars based in United States and United Kingdom. Paul E. Wiedeman's co-authors include James M. Trevillyan, Leo A. Paquette, Stevan W. Djurić, Philip C. Bulman Page, Paul D. Pansegrau, Marina Pliushchev, Stephen J. Ballaron, Richard J. Sciotti, David J. Madar and Karl W. Mollison and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and The FASEB Journal.

In The Last Decade

Paul E. Wiedeman

19 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul E. Wiedeman United States 13 184 179 95 67 66 20 437
J Birnbaum United States 7 52 0.3× 162 0.9× 54 0.6× 129 1.9× 53 0.8× 14 455
Hea‐Young Park Choo South Korea 13 270 1.5× 231 1.3× 70 0.7× 30 0.4× 55 0.8× 37 564
Jacques Gilbert France 12 147 0.8× 147 0.8× 29 0.3× 29 0.4× 38 0.6× 17 420
Kazuyoshi Tomita Japan 10 80 0.4× 158 0.9× 33 0.3× 15 0.2× 25 0.4× 19 379
Laïla El Kihel France 12 114 0.6× 161 0.9× 59 0.6× 14 0.2× 30 0.5× 22 337
Andrea M. Sefler United States 11 191 1.0× 460 2.6× 72 0.8× 100 1.5× 32 0.5× 18 684
Christopher P. Laudeman United States 10 64 0.3× 188 1.1× 22 0.2× 39 0.6× 34 0.5× 15 409
John A. Wos United States 13 285 1.5× 249 1.4× 27 0.3× 31 0.5× 21 0.3× 34 565
Colin J. Theobald United Kingdom 13 142 0.8× 243 1.4× 33 0.3× 9 0.1× 36 0.5× 18 464
Theresa J. Roethke United States 11 56 0.3× 139 0.8× 50 0.5× 22 0.3× 6 0.1× 16 344

Countries citing papers authored by Paul E. Wiedeman

Since Specialization
Citations

This map shows the geographic impact of Paul E. Wiedeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Wiedeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Wiedeman more than expected).

Fields of papers citing papers by Paul E. Wiedeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Wiedeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Wiedeman. The network helps show where Paul E. Wiedeman may publish in the future.

Co-authorship network of co-authors of Paul E. Wiedeman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Wiedeman. A scholar is included among the top collaborators of Paul E. Wiedeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Wiedeman. Paul E. Wiedeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yaya, John K. Pratt, Teresa I. Ng, et al.. (2008). Identification of halosalicylamide derivatives as a novel class of allosteric inhibitors of HCV NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 18(11). 3173–3177. 13 indexed citations
2.
Wiedeman, Paul E.. (2007). 2. DPPIV Inhibition: Promising Therapy for the Treatment of Type 2 Diabetes. Progress in medicinal chemistry. 45. 63–109. 23 indexed citations
3.
Yeh, Vince S. C. & Paul E. Wiedeman. (2006). Practical Cu-catalyzed amination of functionalized heteroaryl halides. Tetrahedron Letters. 47(34). 6011–6016. 15 indexed citations
4.
Longenecker, Kenton L., Kent D. Stewart, David J. Madar, et al.. (2006). Crystal Structures of DPP-IV (CD26) from Rat Kidney Exhibit Flexible Accommodation of Peptidase-Selective Inhibitors. Biochemistry. 45(24). 7474–7482. 32 indexed citations
5.
Wiedeman, Paul E. & James M. Trevillyan. (2005). Dipeptidyl peptidase IV inhibitors for type 2 diabetes and metabolic syndrome. Drug Discovery Today Therapeutic Strategies. 2(2). 143–149. 3 indexed citations
6.
Wiedeman, Paul E. & James M. Trevillyan. (2003). Dipeptidyl peptidase IV inhibitors for the treatment of impaired glucose tolerance and type 2 diabetes.. PubMed. 4(4). 412–20. 51 indexed citations
7.
Sciotti, Richard J., Marina Pliushchev, Paul E. Wiedeman, et al.. (2002). The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class. Bioorganic & Medicinal Chemistry Letters. 12(16). 2121–2123. 49 indexed citations
8.
Trevillyan, James M., X. Grace Chiou, Yung‐Wu Chen, et al.. (2001). Potent Inhibition of NFAT Activation and T Cell Cytokine Production by Novel Low Molecular Weight Pyrazole Compounds. Journal of Biological Chemistry. 276(51). 48118–48126. 85 indexed citations
9.
Madar, David J., Hana Kopecka, Daisy Pireh, et al.. (2001). Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721. Tetrahedron Letters. 42(22). 3681–3684. 37 indexed citations
11.
Trevillyan, James M., X. Grace Chiou, Stephen J. Ballaron, et al.. (1999). Inhibition of p56lckTyrosine Kinase by Isothiazolones. Archives of Biochemistry and Biophysics. 364(1). 19–29. 28 indexed citations
12.
Wiedeman, Paul E., Stephen W. Fesik, Andrew M. Petros, et al.. (1999). Retention of Immunosuppressant Activity in an Ascomycin Analogue Lacking a Hydrogen-Bonding Interaction with FKBP12. Journal of Medicinal Chemistry. 42(21). 4456–4461. 5 indexed citations
13.
Lane, Benjamin C., et al.. (1993). Evaluation of calcineurin's role in the immunosuppressive activity of FK 506, related macrolactams, and cyclosporine.. PubMed. 25(1 Pt 1). 644–6. 4 indexed citations
14.
Fey, Thomas A., Karl W. Mollison, R. A. Krause, et al.. (1992). Heterogeneity in chemokinetic and enzyme release efficacy of c5a analogs across multiple species. The FASEB Journal. 6(5). 2058. 1 indexed citations
15.
Paquette, Leo A., Paul D. Pansegrau, Paul E. Wiedeman, & James P. Springer. (1988). (+)-Pleuromutilin synthetic studies. Examples of intramolecular hydrogen abstraction by the .beta.-carbon of a 2-cyclopentenone subunit with resultant .alpha.-coupling. The Journal of Organic Chemistry. 53(7). 1461–1466. 22 indexed citations
16.
Paquette, Leo A., Paul E. Wiedeman, & Philip C. Bulman Page. (1988). (+)-Pleuromutilin synthetic studies. Degradative and de novo acquisition of a levorotatory tricyclic lactone subunit. The Journal of Organic Chemistry. 53(7). 1441–1450. 28 indexed citations
17.
Paquette, Leo A., Philip C. Bulman Page, Paul D. Pansegrau, & Paul E. Wiedeman. (1988). (+)-Pleuromutilin synthetic studies. Direct degradation to and independent preparation of an advanced diketone intermediate. Demonstration that reconstruction of the eight-membered ring suffers from serious kinetic retardation. The Journal of Organic Chemistry. 53(7). 1450–1460. 17 indexed citations
18.
Paquette, Leo A. & Paul E. Wiedeman. (1985). A relay to (+)-pleuromutilin. I. synthesis of a levorotatory tricyclic lactone subunit. Tetrahedron Letters. 26(13). 1603–1606. 4 indexed citations
19.
McCarthy, James R., et al.. (1985). Stereospecific syntheses of the four diastereomeric 2-amino-5-phenoxycyclopentanols. The Journal of Organic Chemistry. 50(17). 3095–3103. 14 indexed citations
20.
Paquette, Leo A., Paul E. Wiedeman, & Philip C. Bulman Page. (1985). A relay approach to (+)-pleuromutilin. III. direct degradation of the natural product to the key diketone intermediate and its chemospecific functionalization. Tetrahedron Letters. 26(13). 1611–1614. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026